feed,title,long_url,short_url
Benzinga,ICON Scoops Up PRA Health Sciences In $12B Deal,https://benzinga.com/m-a/21/02/19816964/icon-scoops-up-pra-health-sciences-in-12b-deal,
Benzinga,Karyopharm's Partner Antengene Receives Priority Review For Selinexor Application In China,https://benzinga.com/general/biotech/21/02/19816135/karyopharms-partner-antengene-receives-priority-review-for-selinexor-application-in-china,
